Regular biography
Michael T. Hemann is a Fellow at the Massachusetts Institute of Technology, affiliated with the Department of Biology. His research focuses on understanding the genetic basis of chemotherapy resistance in cancers, utilizing mouse models and high-throughput screening technologies. Hemann's work aims to identify novel cancer drug targets and strategies for improving existing therapies. His laboratory investigates mechanisms of drug resistance and explores ways to tailor cancer treatments to specific malignancies. He is also associated with the Koch Institute for Integrative Cancer Research. His research has been published in prominent journals such as Nature Medicine, Cell, and Cancer Research.